{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T16:10:11Z","timestamp":1684858211126},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1991,3,1]],"date-time":"1991-03-01T00:00:00Z","timestamp":667785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1991,3,1]],"date-time":"1991-03-01T00:00:00Z","timestamp":667785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1991,3,1]],"date-time":"1991-03-01T00:00:00Z","timestamp":667785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1991,3,1]],"date-time":"1991-03-01T00:00:00Z","timestamp":667785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World Journal of Microbiology and Biotechnology"],"published-print":{"date-parts":[[1991,3]]},"DOI":"10.1007\/bf00328983","type":"journal-article","created":{"date-parts":[[2004,10,29]],"date-time":"2004-10-29T19:31:54Z","timestamp":1099078314000},"page":"137-149","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The live vector approach\u2014viruses"],"prefix":"10.1007","volume":"7","author":[{"given":"M.","family":"Mackett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00328983_CR1","first-page":"75","volume-title":"High Technology Route to Virus Vaccines","author":"M. Arkenakis","year":"1985","unstructured":"Arkenakis, M. & Roizman, B. 1985 Genetic engineering of herpes simplex virus genomes. In High Technology Route to Virus Vaccines, eds Dreesman, Gordon R., Bronson, Judith G. & Kennedy, Ronald C. pp. 75\u201381. Washington, DC: American Society for Microbiology."},{"key":"BF00328983_CR2","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1002\/j.1460-2075.1985.tb04158.x","volume":"4","author":"A. Ballay","year":"1985","unstructured":"Ballay, A., Levrero, M., Beundia, M.-A., Tiollais, P. & Pericaudet, 1985 In vitro and in vivo synthesis of hepatitis B virus surface antigen and of the receptor for polymerised human serum albumin from recombinant human adenovirus. EMBO Journal\n4, 3861\u20133865.","journal-title":"EMBO Journal"},{"key":"BF00328983_CR3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/aid.1989.5.159","volume":"5","author":"N. Barrett","year":"1989","unstructured":"Barrett, N., Mitterer, A., Mundt, W., Eibl, J., Eibl, M., Gallo, R.C., Moss, B. & Dorner, F. 1989 Large scale production and purification of recombinant derived HIV-1 gp160 and analysis of its immunogenicity. AIDS Research and Human Retroviruses\n5, 159\u2013170.","journal-title":"AIDS Research and Human Retroviruses"},{"key":"BF00328983_CR4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/322373a0","volume":"322","author":"J. Blancou","year":"1986","unstructured":"Blancou, J., Keiny, M.P., Lathe, R., Pastoret, P.P., Soulebot, J.P. & Desmettre, P. 1986 Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature\n322, 373\u2013375.","journal-title":"Nature"},{"key":"BF00328983_CR5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0168-1702(88)90075-5","volume":"10","author":"D.B. Boyle","year":"1988","unstructured":"Boyle, D.B. & Coupar, B.E.H. 1988 Construction of recombinant fowlpox viruses as vectors for poultry vaccines. Virus Research\n10, 343\u2013356.","journal-title":"Virus Research"},{"key":"BF00328983_CR6","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1099\/0022-1317-70-6-1601","volume":"70","author":"B.M. Brochier","year":"1989","unstructured":"Brochier, B.M., Blancou, J., Aubert, M.F.A., Kieny, M.P., Desmettre, P. & Pastoret, P.-P. 1989 Interaction between rabies infection and oral administration of vaccinia-rabies recombinant virus to foxes (Vulpes vulpes). Journal of General Virology, 70, 1601\u20131604.","journal-title":"Journal of General Virology"},{"key":"BF00328983_CR7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-1135(88)90055-7","volume":"18","author":"B.M. Brochier","year":"1988","unstructured":"Brochier, B.M., Languet, B., Blancou, J., Kieny, M.P., Lecocq, J.-P., Costy, F., Desmettre, P. & Pastoret, P.-P. 1988 Use of recombinant vaccinia-rabies virus for oral vaccination of fox cubs (Vulpes vulpes) against rabies. Veterinary Microbiology\n18, 103\u2013108.","journal-title":"Veterinary Microbiology"},{"key":"BF00328983_CR8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1128\/jvi.62.3.866-874.1988","volume":"62","author":"R.M.L. Buller","year":"1988","unstructured":"Buller, R.M.L., Chakrabarti, S., Cooper, J.A., Twardzik, D.R. & Moss, B. 1988 Deletion of the vaccinia growth factor gene reduces virus virulence. Journal of Virology\n62, 866\u2013874.","journal-title":"Journal of Virology"},{"key":"BF00328983_CR9","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/317813a0","volume":"317","author":"R.M.L. Buller","year":"1985","unstructured":"Buller, R.M.L., Smith, G.L., Gerner, K., Notkins, A.L. & Moss, B. 1985 Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature\n317, 813\u2013815.","journal-title":"Nature"},{"key":"BF00328983_CR10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/320535a0","volume":"320","author":"S. Chakrabarti","year":"1986","unstructured":"Chakrabarti, S., Robert-Guroff, M., Wong-Staal, F., Gallo, R.C. & Moss, B. 1986 Expression of the HTLV-III envelope gene by a recombinant vaccinia virus. Nature\n320, 535\u2013537.","journal-title":"Nature"},{"key":"BF00328983_CR11","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1128\/jvi.62.10.3779-3788.1988","volume":"62","author":"B. Chesbro","year":"1988","unstructured":"Chesbro, B. & Wherly, K. 1988 Development of a sensitive quantitative focal assay for human immunodeficiency virus. Journal of Virology\n62, 3779\u20133788.","journal-title":"Journal of Virology"},{"key":"BF00328983_CR12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/330381a0","volume":"330","author":"B.E. Clarke","year":"1987","unstructured":"Clarke, B.E., Newton, S.E., Carroll, A.R., Francis, M.J., Appleyard, G., Syred, A.D., Highfield, P.E., Rowlands, D.J. & Brown, F. 1987 Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature\n330, 381\u2013384.","journal-title":"Nature"},{"key":"BF00328983_CR13","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1128\/jvi.63.10.4464-4468.1989","volume":"63","author":"A. Cordonnier","year":"1989","unstructured":"Cordonnier, A., Riviere, Y., Montagnier, L. & Emerman, M. 1989 Effects of mutations in hyperconversed regions of the extracellular glycoprotein of human immuno-deficiency virus type 1 on receptor binding. Journal of Virology\n63, 4464\u20134468.","journal-title":"Journal of Virology"},{"key":"BF00328983_CR14","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/eji.1830161203","volume":"16","author":"B.E.H. Coupar","year":"1986","unstructured":"Coupar, B.E.H., Andrew, M.E., Both, G.W. & Boyle, D.B. 1986a Temporal regulation of influenza haemagglutinin expression in vaccinia virus recombinants and effects on the immunie response. European Journal of Immunology\n16, 1479\u20131487.","journal-title":"European Journal of Immunology"},{"key":"BF00328983_CR15","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.1073\/pnas.83.20.7879","volume":"83","author":"B.E.H. Coupar","year":"1986","unstructured":"Coupar, B.E.H., Andrew, M.E., Boyle, D.B. & Bladen, R.V. 1986b Immune response to H-2Kd antigen expressed by recombinant vaccinia virus. Proceedings of the National Academy of Sciences of the USA\n83, 7879\u20137882.","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"BF00328983_CR16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1126\/science.2986288","volume":"288","author":"K. Cremer","year":"1985","unstructured":"Cremer, K., Mackett, M., Wohlenberg, C., Notkins, A.L. & Moss, B. 1985 Vaccinia virus recombinants expressing herpes simplex type 1 glycoprotein D prevents latent Herpes infection in mice. Science\n288, 737\u2013740.","journal-title":"Science"},{"key":"BF00328983_CR17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0022-2836(89)90107-1","volume":"210","author":"A.J. Davison","year":"1989","unstructured":"Davison, A.J. & Moss, B. 1989a Structure of vaccinia virus early promoters. Journal of Molecular Biology\n210, 749\u2013769.","journal-title":"Journal of Molecular Biology"},{"key":"BF00328983_CR18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0022-2836(89)90108-3","volume":"210","author":"A.J. Davison","year":"1989","unstructured":"Davison, A.J. & Moss, B. 1989b Structure of vaccinia virus late promoters. Journal of Molecular Biology\n210, 771\u2013784.","journal-title":"Journal of Molecular Biology"},{"key":"BF00328983_CR19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/316268a0","volume":"316","author":"H. De La Salle","year":"1985","unstructured":"De La Salle, H., Altenburger, W., Elkaim, R., Dolt, K., Dieterle, A., Drillien, R., Cuzenave, J.P., Tolstosher, P. & Lecocq, J.P. 1985 Active gamma carboxylated human factor IX is expressed using recombinant DNA techniques. Nature\n316, 268\u2013270.","journal-title":"Nature"},{"key":"BF00328983_CR20","unstructured":"Dulbecco, R. 1983 International patent applications number PCT\/US38\/00015."},{"key":"BF00328983_CR21","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1128\/jvi.64.5.2448-2451.1990","volume":"64","author":"P. Earl","year":"1990","unstructured":"Earl, P., Hugin, A.W. & Moss, B. 1990 Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus. Journal of Virology\n64, 2448\u20132451.","journal-title":"Journal of Virology"},{"key":"BF00328983_CR22","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1073\/pnas.83.6.1906","volume":"83","author":"N. Elango","year":"1986","unstructured":"Elango, N., Prince, G.A., Murphy, B.R., Venkatesan, S., Chanock, R.M. & Moss, B. 1986 Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein. Proceedings of the National Academy of Sciences of the USA\n83, 1906\u20131910.","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"BF00328983_CR23","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1073\/pnas.86.16.6126","volume":"86","author":"O. Elroy-Stein","year":"1989","unstructured":"Elroy-Stein, O., Fuerst, T. & Moss, B. 1989 Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5\u2032 sequence improves the performance of the vaccinia virus\/bacteriophage T7 hybrid expression system. Proceedings of the National Academy of Sciences of the USA\n86, 6126\u20136130.","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"BF00328983_CR24","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1073\/pnas.85.4.1052","volume":"85","author":"C.D. Estin","year":"1988","unstructured":"Estin, C.D., Stevenson, U.S., Plowman, G.D., Hu, S.-L., Sridhar, P., Hellstrom, I. & Brown, J.P. 1988 Recombinant vaccinia virus vaccine aginst the human melanoma antigen p97 for use in immunotherapy. Proceedings of the National Academy of Sciences of the USA\n85, 1052\u20131059.","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"BF00328983_CR25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/339385a0","volume":"339","author":"D.J. Evans","year":"1989","unstructured":"Evans, D.J., McKeating, J., Meredith, J.M., Burke, K.L., Katrak, K., John, A., Ferguson, M., Minor, P.D., Weiss, R.A. & Almond, J.W. 1989 An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature\n339, 385\u2013389.","journal-title":"Nature"},{"key":"BF00328983_CR26","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/jvi.62.6.1849-1854.1988","volume":"62","author":"F.G. Falkner","year":"1988","unstructured":"Falkner, F.G. & Moss, B. 1988 Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. Journal of Virology\n62, 1849\u20131854.","journal-title":"Journal of Virology"},{"key":"BF00328983_CR27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/330259a0","volume":"330","author":"C. Flexner","year":"1987","unstructured":"Flexner, C., Hugin, A. & Moss, B. 1987 Prevention of vaccinia virus infection in immuno-deficient mice by vector derived IL-2 expression. Nature\n330, 259\u2013261.","journal-title":"Nature"},{"key":"BF00328983_CR28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0264-410X(90)90171-H","volume":"8","author":"C. Flexner","year":"1990","unstructured":"Flexner, C., Moss, B., London, W.T. & Murphy, B.R. 1990 Attenuation and immunogenicity in primates of vaccinia virus recombinants expressing human interleukin-2. Vaccine\n8, 17\u201321.","journal-title":"Vaccine"},{"key":"BF00328983_CR29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/335259a0","volume":"335","author":"C. Flexner","year":"1988","unstructured":"Flexner, C., Murphy, B.R., Rooney, J.F., Wohlenberg, C., Yuferov, V., Notkins, A.L. & Moss, B. 1988 Successful vaccination with a polyvalent live vector despite existing immunity to an expressed antigen. Nature\n335, 529\u2013262.","journal-title":"Nature"},{"key":"BF00328983_CR30","first-page":"2538","volume":"7","author":"T.R. Fuerst","year":"1987","unstructured":"Fuerst, T.R., Earl, P.L. & Moss, B. 1987 Use of a vaccinia virus-T7 RNA polymerase system for expression of target genes. Molecular and Cellular Biology\n7, 2538\u20132544.","journal-title":"Molecular and Cellular Biology"},{"key":"BF00328983_CR31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1084\/jem.165.2.408","volume":"165","author":"F. Gotch","year":"1987","unstructured":"Gotch, F., McMichael, A., Smith, G.L. & Moss, B. 1987 Identification of viral molecules recognized by influenza specific human cytotoxic T lymphocytes. Journal of Experimental Medicine\n165, 408\u2013416.","journal-title":"Journal of Experimental Medicine"},{"key":"BF00328983_CR32","doi-asserted-by":"crossref","first-page":"8459","DOI":"10.1016\/S0021-9258(18)81809-9","volume":"264","author":"S.D. Gowda","year":"1989","unstructured":"Gowda, S.D., Stein, B.S. & Engleman, E.G. 1989a Identification of protein intermediates in the processing of p55 HIV-1 gag precursor in cells infected with recombinant vaccinia virus. Journal of Biological Chemistry\n264, 8459\u20138462.","journal-title":"Journal of Biological Chemistry"},{"key":"BF00328983_CR33","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1128\/jvi.63.3.1451-1454.1989","volume":"63","author":"S.D. Gowda","year":"1989","unstructured":"Gowda, S.D., Stein, B.S., Steimer, K.S. & Engleman, E.G. 1989b Expression and processing of human immunodeficiency virus type 1 gag and pol genes by cells infected with a recombinant vaccinia virus. Journal of Virology\n63, 1451\u20131454.","journal-title":"Journal of Virology"},{"key":"BF00328983_CR34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/330266a0","volume":"330","author":"B. Guy","year":"1987","unstructured":"Guy, B., Kieny, M.P., Riviere, Y., Peuch, C.le, Dott, K., Girard, M., Montagnier, L. & Lecocq, J.-P. 1987 HIV F\/3\u2032 orf encodes a phosphorylared GTP-binding protein resembling an oncogene product. Nature\n330, 266\u2013269.","journal-title":"Nature"},{"key":"BF00328983_CR35","first-page":"87","volume-title":"Vaccinia Viruses as Vectors for Vaccine Antigens","author":"S. Hashizume","year":"1985","unstructured":"Hashizume, S., Yoshizawa, H., Morita, M. & Suzuki, K. 1985 Properties of attenuated mutant of vaccinia virus LC16m8 derived from Lister strain. In Vaccinia Viruses as Vectors for Vaccine Antigens, ed. Quinnan, J. pp. 87\u2013100, New York: Elsevier."},{"key":"BF00328983_CR36","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1126\/science.2994218","volume":"229","author":"J.M. Hogle","year":"1985","unstructured":"Hogle, J.M., Chow, M. & Filman, D.J. 1985 Three-dimensional structure of poliovirus at 2.9 A resolution. Science\n229, 1358\u20131365.","journal-title":"Science"},{"key":"BF00328983_CR37","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/328721a0","volume":"328","author":"S.-L. Hu","year":"1987","unstructured":"Hu, S.-L., Fultz, P.N., McClure, H.M., Eichberg, J.W., Thomas, E.K., Zarling, J.M., Singhal, M.C., Kosowski, S.G., Swenson, R.B., Anderson, D.C. & Todaro, G. 1987 Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees. Nature\n328, 721\u2013723.","journal-title":"Nature"},{"key":"BF00328983_CR38","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/320537a0","volume":"320","author":"S.-L. Hu","year":"1986","unstructured":"Hu, S.-L., Kosowski, S.G. & Dalrymple, J.M. 1986 Expression of AIDS virus envelope gene in recombinant vaccinia virus. Nature\n320, 537\u2013540.","journal-title":"Nature"},{"key":"BF00328983_CR39","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1128\/jvi.62.10.3855-3861.1988","volume":"62","author":"C. Huang","year":"1988","unstructured":"Huang, C., Samsanoff, W.A. & Grzelecki, A. 1988 Vaccinia virus recombinants expressing an 11Kd \u03b2-galactosidase fusion protein incorporate active \u03b2-galactosidase in virus particles. Journal of Virology\n62, 3855\u20133861.","journal-title":"Journal of Virology"},{"key":"BF00328983_CR40","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4049\/jimmunol.144.1.290","volume":"144","author":"G. Karupiah","year":"1990","unstructured":"Karupiah, G., Coupar, B.E.H., Andrew, M.E., Boyle, D.B., Phillip, S.M., Mullbacher, A., Blanden, R.V. & Ramshaw, I.A. 1990 Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. Journal of Immunology\n144, 290\u2013298.","journal-title":"Journal of Immunology"},{"key":"BF00328983_CR41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/312163a0","volume":"312","author":"M.P. Kieny","year":"1984","unstructured":"Kieny, M.P., Lathe, R., Drillien, R., Spehner, D., Skory, S., Schmitt, D., Wiktor, T., Koprowski, H. & Lecocq, J.-P. 1984 Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature\n312, 163\u2013166.","journal-title":"Nature"},{"key":"BF00328983_CR42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/protein\/2.3.219","volume":"2","author":"M.P. Kieny","year":"1988","unstructured":"Kieny, M.P., Lathe, R., Riviere, Y., Dott, K., Schmitt, D., Girard, M., Montagnier, L. & Lecocq, J.-P. 1988 Improved antigenicity of the HIV env protein by cleavage site removal. Protein Engineering\n2, 219\u2013225.","journal-title":"Protein Engineering"},{"key":"BF00328983_CR43","first-page":"790","volume":"44","author":"M.P. Kieny","year":"1986","unstructured":"Kieny, M.P., Rautmann, G., Schmitt, D., Dott, K., Wain-Hobson, S., Alizon, M., Girard, M., Chameret, S., Laurent, A., Montagnier, L. & Lecocq, J.-P. 1986 Human immunodeficiency virus env protein expressed from a recombinant vaccinia virus. Biotechnology\n44, 790\u2013795.","journal-title":"Biotechnology"},{"key":"BF00328983_CR44","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1542\/peds.42.6.980","volume":"42","author":"C.H. Kempe","year":"1968","unstructured":"Kempe, C.H., Fulginiti, V., Minimitani, M. & Shienfield, H. 1968 Smallpox vaccination of eczema patients with a strain of attenuated live vaccinia (CV-178). Pediatrics\n42, 980\u2013985.","journal-title":"Pediatrics"},{"key":"BF00328983_CR45","volume-title":"High Technology Route to Virus Vaccines","author":"S. Kit","year":"1985","unstructured":"Kit, S., Kit, M., Lawhorn, B. & McConnell, S. 1985 Immunization of pregnant pigs in a quarantined swine herd with a thymidine kinase deletion mutant of pseudorabies virus. In High Technology Route to Virus Vaccines. Washington, DC: American Society for Microbiology."},{"key":"BF00328983_CR46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/335176a0","volume":"335","author":"G. Kotwai","year":"1988","unstructured":"Kotwai, G. & Moss, B. 1988 Vaccinia encodes a secretory polypeptide structurally related to complement control proteins. Nature\n335, 176\u2013178.","journal-title":"Nature"},{"key":"BF00328983_CR47","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1128\/jvi.63.2.600-606.1989","volume":"63","author":"G.J. Kotwal","year":"1989","unstructured":"Kotwal, G.J. & Moss, B. 1989 Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily. Journal of Virology\n63, 600\u2013606.","journal-title":"Journal of Virology"},{"key":"BF00328983_CR48","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0042-6822(89)90627-2","volume":"171","author":"G.J. Kotwai","year":"1989","unstructured":"Kotwai, G.J., Hugin, A. & Moss, B. 1989 Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da secreted protein. Virology\n171, 579\u2013587.","journal-title":"Virology"},{"key":"BF00328983_CR49","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/jvi.63.2.584-590.1989","volume":"63","author":"R.A. Koup","year":"1989","unstructured":"Koup, R.A., Sullivan, J.L., Levine, P.H., Brewster, F., Mahr, A., Mazzara, G., McKenzie, S. & Panicali, D. 1989 Antigenic specificity antibody-dependent cell-mediated cytotoxicity against human immunodeficiency virus in antibody-positive sera. Journal of Virology\n63, 584\u2013590.","journal-title":"Journal of Virology"},{"key":"BF00328983_CR50","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJM196911272812201","volume":"281","author":"J.M. Lane","year":"1969","unstructured":"Lane, J.M., Ruben, F.L., Neff, J.M. & Millar, J.D. 1969 Complications of smallpox vaccination, 1968. National surveillance in the United States. New England Journal of Medicine\n281, 1201\u20131208.","journal-title":"New England Journal of Medicine"},{"key":"BF00328983_CR51","first-page":"3191","volume":"6","author":"C.J. Langford","year":"1986","unstructured":"Langford, C.J., Edwards, S.J., Smith, G.L., Mitchell, G.F., Moss, B., Kemp, D.J. & Anders, R.F. 1986 Anchoring a secreted plasmodium antigen on the surface of recombinant vaccinia virus infected cells increases its immunogenicity. Molecular and Cellular Biology\n6, 3191\u20133199.","journal-title":"Molecular and Cellular Biology"},{"key":"BF00328983_CR52","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/326878a0","volume":"326","author":"R. Lathe","year":"1987","unstructured":"Lathe, R., Kieny, M.P., Gerhinger, P., Clertant, P., Guizani, I., Cuzin, R. & Chambon, P. 1987 Tumour prevention and rejection by vaccinia recombinants. Nature\n326, 878\u2013880.","journal-title":"Nature"},{"key":"BF00328983_CR53","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/323725a0","volume":"323","author":"J.D. Lifson","year":"1986","unstructured":"Lifson, J.D., Feinberg, M.B., Reyes, G.R., Rabin, L., Banapour, B., Chakrabarti, S., Moss, B., Wong-Staal, F., Steiner, K.S. & Engleman, E.G. 1986 Induction of CD4-dependent cell fusion by the HTLVIII\/LAV envelope glycoprotein. Nature\n323, 725\u2013728.","journal-title":"Nature"},{"key":"BF00328983_CR54","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1073\/pnas.84.11.3896","volume":"84","author":"R.S. Lowe","year":"1987","unstructured":"Lowe, R.S., Keller, P.M., Keech, B.J., Davison, A.J., Whang, Y., Morgan, A.J., Kieff, E. & Ellis, R.W., 1987 Varicellazoster virus as a live vector for the expression of foreign genes. Proceedings of the National Academy of Sciences of the USA\n84, 3896.","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"BF00328983_CR55","first-page":"21","volume":"1","author":"M. Mackett","year":"1990","unstructured":"Mackett, M. 1990 Vaccinia virus recombinants. Advances in Gene Technology\n1, 21\u201354.","journal-title":"Advances in Gene Technology"},{"key":"BF00328983_CR56","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1002\/j.1460-2075.1985.tb04070.x","volume":"4","author":"M. Mackett","year":"1985","unstructured":"Mackett, M. & Arrand, J.R. 1985 Recombinant vaccinia virus induces neutralising antibodies in rabbits against Epstein-Barr virus membrane antigen gp340. EMBO Journal\n4, 3229\u20133234.","journal-title":"EMBO Journal"},{"key":"BF00328983_CR57","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1128\/jvi.64.6.2545-2552.1990","volume":"64","author":"M. Mackett","year":"1990","unstructured":"Mackett, M., Conway, M.J., Arrand, J.R., Haddad, R.W. & Hutt-Fletcher, L. 1990. Characterization and expression of a glycoprotein encoded by the Epstein-Barr virus BamHI I fragment. Journal of Virology\n64, 2545\u20132552.","journal-title":"Journal of Virology"},{"key":"BF00328983_CR58","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1126\/science.2981435","volume":"227","author":"M. Mackett","year":"1985","unstructured":"Mackett, M., Yilma, T., Rose, J. & Moss, B. 1985 Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle. Science\n227, 433\u2013435.","journal-title":"Science"},{"key":"BF00328983_CR59","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jmv.1890250209","volume":"25","author":"A.J. Morgan","year":"1988","unstructured":"Morgan, A.J., Mackett, M., Finnerty, S., Arrand, J.R., Scullion, F.T. & Epstein, M.A. 1988 Recombinant vaccinia virus expressing Epstein-Barr virus glycoprotein gp340 protects cotton top tamarins against EB-virus induced lymphomas. Journal of Medical Virology\n25, 189\u2013195.","journal-title":"Journal of Medical Virology"},{"key":"BF00328983_CR60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0264-410X(87)90012-0","volume":"5","author":"M. Morita","year":"1987","unstructured":"Morita, M., Suzuki, K., Yasuda, A., Kojima, A., Sugimoto, M., Watanabe, K., Kobayashi, H., Kajima, K. & Hashizume, S. 1987 Recombinant vaccinia virus LC16m0 or LC16m8 that express hepatitis B surface antigen while preserving the attenuation of the parental strain. Vaccine\n5, 65\u201370.","journal-title":"Vaccine"},{"key":"BF00328983_CR61","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/311067a0","volume":"311","author":"B. Moss","year":"1984","unstructured":"Moss, B., Smith, G.L., Gerin, J.L. & Purcell, R.H. 1984 Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature\n311, 67\u201369.","journal-title":"Nature"},{"key":"BF00328983_CR62","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1073\/pnas.83.19.7462","volume":"83","author":"R.A. Olmstead","year":"1986","unstructured":"Olmstead, R.A., Elango, N., Prince, G.A., Murphy, B.R., Johnson, P.R., Moss, B., Chanock, R.M. & Collins, P.L., 1986 Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: Comparison of the individual contributions of the F and G glycoprotein to host immunity. Proceedings of the National Academy of Sciences of the USA\n83, 7462\u20137466.","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"BF00328983_CR63","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1126\/science.2992092","volume":"229","author":"M.E. Perkus","year":"1985","unstructured":"Perkus, M.E., Puccini, A., Lipinskas, B.R. & Paoletti, E. 1985 Recombinant vaccinia virus: Immunization against multiple pathogens. Science\n229, 728\u2013731.","journal-title":"Science"},{"key":"BF00328983_CR64","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1099\/0022-1317-71-8-1697","volume":"71","author":"J.R. Putnak","year":"1990","unstructured":"Putnak, J.R. & Schlesinger, J.J. 1990 Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever non-structural proteins NS1,NS2a and NS2b. Journal of General Virology\n71, 1697\u20131702.","journal-title":"Journal of General Virology"},{"key":"BF00328983_CR65","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.6272391","volume":"214","author":"V.R. Racaniello","year":"1981","unstructured":"Racaniello, V.R. & Baltimore, D. 1981 Cloned poliovirus complementary DNA is infectious in mammalian cells. Science\n214, 916\u2013919.","journal-title":"Science"},{"key":"BF00328983_CR66","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/329545a0","volume":"329","author":"I.A. Ramshaw","year":"1987","unstructured":"Ramshaw, I.A., Andrew, M.E., Phillips, S.M., Boyle, D.B. & Coupar, B.E.H. 1987 Recovery of immunodeficient mice from a vaccinia virus\/IL-2 recombinant infection. Nature\n329, 545\u2013546.","journal-title":"Nature"},{"key":"BF00328983_CR67","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM198703123161106","volume":"316","author":"R.R. Redfield","year":"1987","unstructured":"Redfield, R.R., Wright, D.C., James, W.D., Jones, T.S., Brown, C. & Burke, D.S. 1987 Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. New England Journal of Medicine\n316, 673\u2013676.","journal-title":"New England Journal of Medicine"},{"key":"BF00328983_CR68","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1073\/pnas.86.4.1287","volume":"86","author":"D. Rodriguez","year":"1989","unstructured":"Rodriguez, D., Rodriguez, J.-R., Rodriguez, J.F., Trauber, D. & Esteban, M. 1989 Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses. Proceedings of the National Academy of Sciences of the USA\n86, 1287\u20131291.","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"BF00328983_CR69","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1128\/jvi.62.5.1530-1534.1988","volume":"62","author":"J.F. Rooney","year":"1988","unstructured":"Rooney, J.F., Wohlenburg, C., Cremer, K.J., Moss, B. & Notkins, A.L. 1988 Immunization with a vaccinia virus recombinant expressing herpes simplex type 1 glycoprotein D: long-term protection and effect of revaccination. Journal of Virology\n62, 1530\u20131534.","journal-title":"Journal of Virology"},{"key":"BF00328983_CR70","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1073\/pnas.83.20.7947","volume":"83","author":"C.E. Rupprecht","year":"1986","unstructured":"Rupprecht, C.E., Wiktor, T.J.A., Johnston, D.H., Hamir, A.N., Dietzschold, B., Wunner, W.H., Glickman, L.T. & Koprowski, H. 1986 Oral immunization and protection of racoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine. Proceedings of the National Academy of Sciences of the USA\n83, 7947\u20137950.","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"BF00328983_CR71","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/infdis\/157.6.1260","volume":"157","author":"D.H. Shepp","year":"1988","unstructured":"Shepp, D.H., Chakrabarti, S., Moss, B. & QuinnanJr, G.V. 1988 Antibody-dependent cellular cytotoxicity specific for the envelope antigens of human immunodeficiency virus. Journal of Infectious Diseases\n157, 1260\u20131264.","journal-title":"Journal of Infectious Diseases"},{"key":"BF00328983_CR72","series-title":"Society for General Microbiology Symposium","first-page":"77","volume-title":"Control of Virus Disease","author":"G.L. Smith","year":"1990","unstructured":"Smith, G.L. 1990 Vaccinia: virus, vector and vaccine. In Control of Virus Disease, Society for General Microbiology Symposium 45, eds Dimmock, N.B.J., Griffiths, P.D. & Madeley, C.R.. Cambridge, UK: Cambridge University Press; 77\u2013121."},{"key":"BF00328983_CR73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0378-1119(83)90163-4","volume":"25","author":"G.L. Smith","year":"1983","unstructured":"Smith, G.L. & Moss, B. 1983 Infectious poxvirus vectors have capacity for at least 25,000 base pairs of foreign DNA. Gene\n25, 21\u201328.","journal-title":"Gene"},{"key":"BF00328983_CR74","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1099\/0022-1317-70-9-2333","volume":"70","author":"G.L. Smith","year":"1989","unstructured":"Smith, G.L., Howard, S.T. & Chan, Y.S. 1989 Vaccinia virus encodes a family of genes with homology to serine protease inhibitors. Journal of General Virology\n70, 2333\u20132343.","journal-title":"Journal of General Virology"},{"key":"BF00328983_CR75","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1073\/pnas.80.23.7155","volume":"80","author":"G.L. Smith","year":"1983","unstructured":"Smith, G.L., Murphy, B.R. & Moss, B. 1983 Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza haemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proceedings of the National Academy of Sciences of the USA\n80, 7155\u20137159.","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"BF00328983_CR76","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/jvi.57.3.1187-1190.1986","volume":"57","author":"G. Stanway","year":"1986","unstructured":"Stanway, G., Hughes, P.J., Westrop, G.D., Evans, D.M.A., Dunn, G., Minor, P.D., Schild, G.C. & Almond, J.W. 1986 Construction of poliovirus intertypic recombinants by use of cDNA. Journal of Virology\n57, 1187\u20131190.","journal-title":"Journal of Virology"},{"key":"BF00328983_CR77","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/j.1460-2075.1986.tb04204.x","volume":"5","author":"E.B. Stephens","year":"1986","unstructured":"Stephens, E.B., Compans, R.W., Earl, P. & Moss, B. 1986 Surface expression of viral glycoproteins is polarised in epithelial cells infected with recombinant vaccinia viral vectors. EMBO Journal\n5, 237\u2013245.","journal-title":"EMBO Journal"},{"key":"BF00328983_CR78","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/nar\/16.6.2431","volume":"16","author":"H.G. Stunnenberg","year":"1988","unstructured":"Stunnenberg, H.G., Lange, H., Philipson, L., Van Miltenburg, R.T. & Van Der Vliet, P.C. 1988 High expression of functional adenovirus DNA polymerase and precursor terminal protein using recombinant vaccinia virus. Nucleic Acids Research\n16, 2431\u20132444.","journal-title":"Nucleic Acids Research"},{"key":"BF00328983_CR79","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/jvi.64.4.1549-1555.1990","volume":"64","author":"J.A. Suzich","year":"1990","unstructured":"Suzich, J.A., Kakach, L.T. & Collett, M.S. 1990 Expression in strategy of a phlebovirus: Biogenesis of proteins from the rift valley fever virus M segment. Journal of Virology\n64, 1549\u20131555.","journal-title":"Journal of Virology"},{"key":"BF00328983_CR80","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1099\/0022-1317-68-10-2705","volume":"68","author":"F. Takahashi-Nishimaki","year":"1987","unstructured":"Takahashi-Nishimaki, F., Suzuki, K., Morita, M., Muruyama, T. Miki, K., Hashizume, S. & Sugimoto, M. 1987 Genetic analysis of vaccinia virus Lister strain and its attenuated mutant LC16m8: Production of intermediate variants by homologous recombination. Journal of General Virology\n68, 2705\u20132710.","journal-title":"Journal of General Virology"},{"key":"BF00328983_CR81","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/jvi.64.4.1441-1450.1990","volume":"64","author":"J. Taylor","year":"1990","unstructured":"Taylor, J., Edbauer, C., Rey-Senelonge, A., Bouquet, J.-F., Norton, E., Goebel, S., Desmettre, P. & Paoletti, E. 1990 Newcastle disease virus fusion protein expressed in fowlpox virus recombinant confers protection in chickens. Journal of Virology\n64, 1441\u20131450.","journal-title":"Journal of Virology"},{"key":"BF00328983_CR82","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/0264-410X(88)90101-6","volume":"6","author":"J. Taylor","year":"1988","unstructured":"Taylor, J., Weinberg, R., Kawaoka, Y., Webster, R. & Paoletti, E. 1988 Protective immunity against avian influenza induced by a fowlopox virus recombinant. Vaccine\n6, 504\u2013508.","journal-title":"Vaccine"},{"key":"BF00328983_CR83","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1126\/science.3754979","volume":"232","author":"G. Thomas","year":"1986","unstructured":"Thomas, G., Herbert, E. & Hruby, D.E. 1986 Expression and cell type specific processing of human preproenkephalin with a vaccinia recombinant. Science\n232, 1641\u20131643.","journal-title":"Science"},{"key":"BF00328983_CR84","first-page":"363","volume":"51","author":"N.D. Tolson","year":"1987","unstructured":"Tolson, N.D., Charlton, K.M., Stewart, R.B., Campbell, J.B. & Wiktor, T.J. 1987 Immune response in skunks to a vaccinia virus recombinant expressing the rabies virus glycoprotein. Canadian Journal of Veterinary Research\n51, 363\u2013366.","journal-title":"Canadian Journal of Veterinary Research"},{"key":"BF00328983_CR85","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/aid.1989.5.41","volume":"5","author":"J.-P. Van Eendenburg","year":"1989","unstructured":"Van Eendenburg, J.-P., Yagello, M., Girard, M., Kieny, M.-P., Lecocq, J.-P., Muchmore, E., Fultz, P.N., Riviere, Y., Montagnier, L. & Gluckman, J.-C. 1989 Cell mediated immune proliferative responses to HIV-1 of chimpanzees vaccinated with different vaccinia recombinants. AIDS Research and Human Retroviruses\n5, 41\u201349","journal-title":"AIDS Research and Human Retroviruses"},{"key":"BF00328983_CR86","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/328345a0","volume":"328","author":"B.D. Walker","year":"1987","unstructured":"Walker, B.D., Chakrabarti, S., Moss, B., Paradis, T.J., Flynn, T., Durno, A.G., Blumberg, R.S., Kaplan, J.C., Hirsch, M.S. & Schooley, R.T. 1987 HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature\n328, 345\u2013348.","journal-title":"Nature"},{"key":"BF00328983_CR87","doi-asserted-by":"crossref","first-page":"9514","DOI":"10.1073\/pnas.86.23.9514","volume":"86","author":"B.D. Walker","year":"1989","unstructured":"Walker, B.D., Flexner, C., Birch-Limbereger, K., Fischer, L., Paradis, T.J., Aldorini, A., Young, R., Moss, B. & Schooley, R.T. 1989 Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences of the USA\n86, 9514\u20139518.","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"BF00328983_CR88","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1128\/jvi.62.3.687-695.1988","volume":"62","author":"J.L. Whitton","year":"1988","unstructured":"Whitton, J.L., Gebhard, J.R., Lewicki, H., Tishon, A. & Oldstone, M. 1988 Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus. Journal of Virology\n62, 687\u2013695.","journal-title":"Journal of Virology"},{"key":"BF00328983_CR89","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0769-2617(85)80132-5","volume":"136E","author":"T.J. Wiktor","year":"1985","unstructured":"Wiktor, T.J., MacFarlan, R.I., Dietzschold, B., Rupprecht, C. & Wunner, W.H. 1985 Immunogenic properties of vaccinia recombinant virus expressing the rabies glycoprotein. Annles Virologique, Institute Pasteur, Paris 136E, 405\u2013411.","journal-title":"Annles Virologique, Institute Pasteur, Paris"},{"key":"BF00328983_CR90","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1073\/pnas.81.22.7194","volume":"81","author":"T.J. Wiktor","year":"1984","unstructured":"Wiktor, T.J., MacFarlan, R.I., Reagan, K.J., Dietzchold, B., Curtis, P.J., Wunner, W.H., Kieny, M.P., Lathe, R., Lecocq, J.-P., Mackett, M., Moss, B. & Koprowski, H. 1984 Protection from rabies by a vaccinia virus recombinat containing the rabies virus glycoprotein gene. Proceedings of the National Academy of Sciences of the USA\n81, 7194\u20137198.","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"BF00328983_CR91","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1126\/science.3194758","volume":"242","author":"T. Yilma","year":"1988","unstructured":"Yilma, T., Hsu, D., Jones, L., Owens, S., Grubman, M., Mebus, C., Yamanaka, M. & Dale, B. 1988 Protection of cattle against rinderpest with vaccinia recombinants expressing the HA or F gene. Science\n242, 1058\u20131061.","journal-title":"Science"},{"key":"BF00328983_CR92","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/hyb.1987.6.329","volume":"6","author":"T. Yilma","year":"1987","unstructured":"Yilma, T., Ristow, S.S., Moss, B. & Jones, L. 1987 A novel approach for the production of monoclonal antibodies using infectious vaccinia virus recombinants. Hybridoma\n6, 329\u2013335.","journal-title":"Hybridoma"},{"key":"BF00328983_CR93","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/332728a0","volume":"322","author":"D. Zagury","year":"1988","unstructured":"Zagury, D., Bernard, J., Cheynier, R., Desportes, I., Leonard, R., Fouchard, M., Reviel, B., Ittele, D., Lurhuma, Z., Mbayo, K., Wane, J., Salaun, J.-J., Goussard, B., Dechazai, L., Burny, A., Nara, P. & Gallo, R.C. 1988 A group specific anamnestic immune reaction against HIV1 induced by a candidate vaccine against AIDS. Nature\n322, 728\u2013731.","journal-title":"Nature"},{"key":"BF00328983_CR94","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/326249a0","volume":"326","author":"D. Zagury","year":"1987","unstructured":"Zagury, D., Leonard, R., Fouchard, M., Reveil, B., Bernard, J., Ittelr, D., Cattan, A., Zirimwabagabo, L., Kalumbu, M., Justin, W., Salaun, J.-J. & Goussard, B. 1987 Immunization against AIDS in humans. Nature\n326, 249\u2013250.","journal-title":"Nature"},{"key":"BF00328983_CR95","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4049\/jimmunol.139.4.988","volume":"139","author":"J.M. Zarling","year":"1987","unstructured":"Zarling, J.M., Eichberg, J.W., Moran, P.A., McClure, J., Sridhar, P. & Hu, S.-L. 1987 Proliferative and cytotoxic T cells with AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins. Journal of Immunology\n139, 988\u2013990.","journal-title":"Journal of Immunology"}],"container-title":["World Journal of Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00328983.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00328983\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00328983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00328983.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T15:49:28Z","timestamp":1684856968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00328983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,3]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1991,3]]}},"alternative-id":["BF00328983"],"URL":"https:\/\/doi.org\/10.1007\/bf00328983","relation":{},"ISSN":["0959-3993","1573-0972"],"issn-type":[{"value":"0959-3993","type":"print"},{"value":"1573-0972","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,3]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}